The therapeutic effects of blocking CXXC5-Dvl interactions have been demonstrated in animal models for treating AD, skin healing, angiogenesis, bone formation, and hair regeneration [25, 26, 46, 57–59, 63, 71, 72, 76–80, 82, 83, 103–105]. The gene discussed is DVL1; the disease is Alzheimer disease.